Athira Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Athira Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
  • Athira Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 38.4M shares, a 1% increase year-over-year.
  • Athira Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 38M shares, a 0.76% increase from 2022.
  • Athira Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.7M shares, a 2.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 38.4M +380K +1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 38.3M +398K +1.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 38M +287K +0.76% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 38.1M +237K +0.63% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 38M +332K +0.88% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 37.9M +330K +0.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 37.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 37.8M +505K +1.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 37.7M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 37.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 37.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.